Compound 1151
Identifiers
- Canonical SMILES:
COC(=O)c1ccc(cc1Cl)-n1[nH]c2c3cnn(C)c3nc(-c3cccc(c3)C(F)(F)F)c2c1=O
- InChi:
InChI=1S/C23H15ClF3N5O3/c1-31-20-15(10-28-31)19-17(18(29-20)11-4-3-5-12(8-11)23(25,26)27)21(33)32(30-19)13-6-7-14(16(24)9-13)22(34)35-2/h3-10,30H,1-2H3
- InChiKey:
SAOYJICYGMWIQD-UHFFFAOYSA-N
External links
![]() 168317887 |
External search
|
|
|
|
|
Bibliography (1)
Pharmacological data
| Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
|---|---|---|---|
| 1 | 0 | 0 | 0 |
Targets
| PPI family | Best activity | Diseases | MMoA |
|---|---|---|---|
| CD80 / CD28 | 7.39 | cancer | Inhibition |
Physicochemical filters
| Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
|---|---|---|---|---|
| Compliance | ||||
| MW | 501.08 g/mol | |||
| HBA | 8 | |||
| HBD | 1 | |||
| HBA + HBD | 9 | |||
| AlogP | 5.60 | |||
| TPSA | 89.35 | |||
| RB | 5 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
| Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
|---|---|---|---|---|
| 1 | 1 | 0 | 0 | 0 |
| Ta | Structure | Name | Drugbank ID |
|---|---|---|---|
| 0.4766 | ATX-914 | DB12673 | |
| 0.4720 | Riociguat | DB08931 | |
| 0.4714 | 6-CHLORO-9-HYDROXY-1,3-DIMETHYL-1,9-DIHYDRO-4H-PYRAZOLO[3,4-B]QUINOLIN-4-ONE | DB07218 | |
| 0.4574 | Vericiguat | DB15456 | |
| 0.4534 | Decoglurant | DB11923 | |
| 0.4444 | MK-0249 | DB11910 | |
| 0.4424 | Risdiplam | DB15305 | |
| 0.4390 | Tepotinib | DB15133 | |
| 0.4375 | N-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide | DB08349 | |
| 0.4359 | 5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine | DB08531 | |
| 0.4357 | MK-6186 | DB12999 | |
| 0.4350 | Dilmapimod | DB12140 | |
| 0.4303 | Ravoxertinib | DB15281 | |
| 0.4270 | Merestinib | DB12381 | |
| 0.4267 | 5-(2-fluorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine | DB08534 |




